3625 results for «292»

Filter By

3625 results

ACC 2019 Day 3: SAFARI-STEMI, STOPDAPT-2, SMART-CHOICE and more

19 Mar 2019

Mirvat Al Asnag reported live on major late-breaking trials presented at ACC 2019 in New Orleans: SAFARI-STEMI, STOPDAPT-2, SMART-CHOICE, TREAT and more

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
ACC 2019 Day 3: SAFARI-STEMI, STOPDAPT-2, SMART-CHOICE and more

iFR-SWEDEHEART: iFR vs FFR-Guided Coronary Revascularisation

04 Nov 2021

Nicola Ryan reviews the iFR Swedeheart multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) for enrolment randomisation and follow up. At one year follow up iFR guided revascularisation was shown to be non-inferior to FFR guided revascularisation, these results...

Nicola Ryan

Author

Nicola Ryan
iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

Disrupt CAD III: Safety and effectiveness of intravascular lithotripsy for treatment of severe coronary calcification

17 Oct 2020

At TCT Connect 2020, Dean Kereiakes presented the results of the Disrupt CAD III trial. Giuseppe Di Gioia and Dejan Milasinovic provide a summary of the key messages.

Giuseppe Di Gioia

Author

Giuseppe Di Gioia
Dejan Milasinovic

Author

Dejan Milasinovic
Live from TCT Connect 2020: The Disrupt CAD III trial

A large-scale, randomized trial of orbital atherectomy vs. conventional balloon angioplasty in severely calcified coronary arteries prior to DES implantation (ECLIPSE)

30 Oct 2024

Nicola Ryan provides her take on the ECLIPSE trial presented by Ajay J. Kirtane at TCT 2024 in Washington.

Nicola Ryan

Author

Nicola Ryan
A large-scale, randomized trial of orbital atherectomy vs. conventional balloon angioplasty in severely calcified coronary arteries prior to DES implantation (ECLIPSE)

Surgical left atrial appendage occlusion in VHD without AF: OPINION Trial

03 Sep 2025

Alex Sticchi provides his take on the results of the OPINION trial presented by Yang Wang at the ESC Congress 2025 in Madrid.

Alessandro Sticchi

Author

Alessandro Sticchi
OPINION Trial: 1-year outcomes
Didn’t find what you were looking for?